StonvexLoading…
StonvexStonvexStonvexCore line items from ELV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $199.13B | $177.01B | $171.34B | $156.59B |
Operating Income | $7.20B | $7.86B | $8.50B | $8.28B |
Net Income | $5.66B | $5.98B | $5.99B | $5.89B |
EPS (Diluted) | $25.21 | $25.68 | $25.22 | $24.28 |
Total Assets | $121.49B | $116.89B | $108.93B | $102.75B |
Total Liabilities | $77.47B | $75.46B | $69.52B | $66.42B |
Cash & Equivalents | $9.49B | $8.29B | $6.53B | $7.39B |
Free Cash Flow OCF − CapEx | $3.17B | $4.55B | $6.76B | $7.25B |
Shares Outstanding | 220.72M | 227.48M | 233.07M | 237.96M |